NTXBIO - Trademark Details
Status: 700 - Registered
Serial Number
87899061
Registration Number
5968169
Word Mark
NTXBIO
Status
700 - Registered
Status Date
2020-01-21
Filing Date
2018-04-28
Registration Number
5968169
Registration Date
2020-01-21
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2019-04-09
Attorney Name
Law Office Assigned Location Code
L40
Employee Name
DONEGAN, DANIEL P
Statements
Goods and Services
Cell-free protein synthesizing system; Pharmaceutical and biopharmaceutical compounds for use in pharmaceutical, biotechnology, medical and diagnostic application; Novel antibiotic and compounds; Proteins generated using a cell-free protein synthesizing system
Goods and Services
Custom manufacturer of pharmaceutical and biopharmaceutical compounds, namely, antibiotics, proteins, vaccines, enzymes, and small molecules
Goods and Services
Research and development of pharmaceuticals, therapeutics, and biologics, namely, vaccines, antibiotics, vaccines generated in a cell-free protein synthesizing system, antibiotics generated in a cell-free protein synthesizing system, proteins generated in a cell-free protein synthesizing system, and enzymes generated in a cell-free protein synthesizing system; research and development in the field of bioinformatics and production of proteins in cell-free systems for the development of vaccines, and antibiotics; medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; research and development of new drug compounds for therapeutic use; research and development of new biological products for therapeutic use; research and development of antibiotic compounds for therapeutic use; research and development of methods of high-throughput screening of biological materials; research and development of methods of rapid-prototyping of biological materials; research and development of methods of real-time metabolic profiling of bacteria, fungi and plants to discover, characterize and produce bioactive products; design and development of nucleic acids, proteins, enzymes, antibiotic compounds, and drug compounds for use in pharmaceuticals, biotechnology, and medical and diagnostic applications using predictive bioinformatics; bioinformatics scientific research services, namely, identifying new drug compounds from analysis of genomic data
Pseudo Mark
NTX BIO
Classification Information
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2019-02-26
Primary Code
040
First Use Anywhere Date
2015-12-15
First Use In Commerce Date
2017-07-28
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-05-08
Primary Code
042
First Use Anywhere Date
2015-12-15
First Use In Commerce Date
2017-07-28
Current Trademark Owners
Party Name
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
DAVID KERR
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2018-05-02 | NEW APPLICATION ENTERED IN TRAM |
| 2018-05-08 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2018-08-20 | ASSIGNED TO EXAMINER |
| 2018-08-21 | PRIORITY ACTION WRITTEN |
| 2018-08-21 | PRIORITY ACTION E-MAILED |
| 2018-08-21 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| 2019-02-18 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2019-02-25 | ASSIGNED TO LIE |
| 2019-02-25 | ASSIGNED TO LIE |
| 2019-02-26 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2019-02-26 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2019-02-27 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2019-03-20 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2019-04-09 | PUBLISHED FOR OPPOSITION |
| 2019-04-09 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2019-06-04 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2019-12-03 | TEAS STATEMENT OF USE RECEIVED |
| 2019-12-10 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2019-12-03 | USE AMENDMENT FILED |
| 2019-12-10 | STATEMENT OF USE PROCESSING COMPLETE |
| 2019-12-16 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 2019-12-17 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 2020-01-21 | REGISTERED-PRINCIPAL REGISTER |
| 2020-12-09 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
